These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25437223)

  • 1. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
    Litton E; Baker S; Erber W; French C; Ferrier J; Hawkins D; Higgins AM; Hofmann A; Keulenaer BL; Farmer S; McMorrow J; Olynyk J; Richards T; Towler S; Webb S;
    Crit Care Resusc; 2014 Dec; 16(4):285-90. PubMed ID: 25437223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
    ; Litton E; Baker S; Erber WN; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S;
    Intensive Care Med; 2016 Nov; 42(11):1715-1722. PubMed ID: 27686346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
    Laso-Morales MJ; Vives R; Vallejo-Tarrat A; Caló N; Valle-Beltran A; Pontes C
    Trials; 2019 Jan; 20(1):23. PubMed ID: 30616657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial.
    Bernabeu-Wittel M; Romero M; Ollero-Baturone M; Aparicio R; Murcia-Zaragoza J; Rincón-Gómez M; Monte-Secades R; Melero-Bascones M; Rosso CM; Ruiz-Cantero A;
    Transfusion; 2016 Sep; 56(9):2199-211. PubMed ID: 27195774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
    Ghio AJ
    Crit Care Resusc; 2015 Jun; 17(2):144. PubMed ID: 26017134
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
    Spahn DR; Schoenrath F; Spahn GH; Seifert B; Stein P; Theusinger OM; Kaserer A; Hegemann I; Hofmann A; Maisano F; Falk V
    Lancet; 2019 Jun; 393(10187):2201-2212. PubMed ID: 31036337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
    Khalafallah AA; Yan C; Al-Badri R; Robinson E; Kirkby BE; Ingram E; Gray Z; Khelgi V; Robertson IK; Kirkby BP
    Lancet Haematol; 2016 Sep; 3(9):e415-25. PubMed ID: 27570088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
    Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA
    BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Van Wyck DB; Martens MG; Seid MH; Baker JB; Mangione A
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
    Bisbe E; Moltó L; Arroyo R; Muniesa JM; Tejero M
    Br J Anaesth; 2014 Sep; 113(3):402-9. PubMed ID: 24780615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial.
    Richards T; Clevenger B; Keidan J; Collier T; Klein AA; Anker SD; Kelly JD
    Trials; 2015 Jun; 16():254. PubMed ID: 26041028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection.
    Young PJ; Saxena MK; Bellomo R; Freebairn RC; Hammond NE; van Haren FM; Henderson SJ; McArthur CJ; McGuinness SP; Mackle D; Myburgh JA; Weatherall M; Webb SA; Beasley RW;
    Crit Care Resusc; 2012 Dec; 14(4):290-6. PubMed ID: 23230878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.
    Shah A; Chester-Jones M; Dutton SJ; Marian IR; Barber VS; Griffith DM; Singleton J; Wray K; James T; Drakesmith H; Robbins PA; Frise MC; Young JD; Walsh TS; McKechnie SR; Stanworth SJ;
    Br J Anaesth; 2022 Feb; 128(2):272-282. PubMed ID: 34872717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.
    Litton E; Baker S; Erber W; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S; ;
    J Intensive Care; 2018; 6():60. PubMed ID: 30214812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
    Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial.
    Mwangi MN; Mzembe G; Moya E; Braat S; Harding R; Robberstad B; Simpson J; Stones W; Rogerson S; Biselele K; Chinkhumba J; Larson L; Ataíde R; Phiri KS; Pasricha SR
    BMJ Open; 2021 Nov; 11(11):e053288. PubMed ID: 34815287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer.
    Keeler BD; Simpson JA; Ng S; Tselepis C; Iqbal T; Brookes MJ; Acheson AG
    Colorectal Dis; 2014 Oct; 16(10):794-800. PubMed ID: 24916374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial.
    Reim D; Kim YW; Nam BH; Kim MJ; Yook JH; Park YK; Roh SH; Yu WS; Bae JM
    Trials; 2014 Apr; 15():111. PubMed ID: 24708660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.